Donor-derived Infections Among Chinese Donation After Cardiac Death Liver Recipients

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2017 Sep 9

PMID 28883707

Citations 8

Authors

Qi-Fa Ye

Wei Zhou

Qi-Quan Wan

Affiliations

Soon will be listed here.

Abstract

Aim: To investigate blood cultures of deceased donors and report the confirmed transmission of bacterial infection from donors to liver recipients.

Methods: We retrospectively studied the results of blood cultures among our donation after cardiac death (DCD) donors and calculated the donor-derived bacterial infection rates among liver recipients. Study participants underwent liver transplantation between January 1, 2010 and February 1, 2017. The study involved a total of 67 recipients of liver grafts from 67 DCD donors. We extracted the data of donors' and patients' characteristics, culture results and clinical outcomes, especially the post-transplant complications in liver recipients, from electronic medical records. We analyzed the characteristics of the donors and the corresponding liver recipients with emphasis put on donor-derived infections.

Results: Head trauma was the most common origin of death among our 67 DCD donors (46.3%). Blood taken prior to the procurement operation was cultured for 53 of the donors, with 17 episodes of bloodstream infections developing from 13 donors. The predominant organism isolated from the blood of donors was Gram-positive bacteria (70.6%). Only three (4.5%) of 67 liver recipients developed confirmed donor-derived bacterial infections, with two isolates of multidrug-resistant Klebsiella pneumoniae and one isolate of multidrug-resistant Enterobacter aerogenes. The liver recipients with donor-derived infections showed relation to higher crude mortality and graft loss rates (33.3% each) within 3 mo post transplantation, as compared to those without donor-derived infections (9.4% and 4.7%, respectively). All three liver recipients received appropriate antimicrobial therapy.

Conclusion: Liver recipients have high occurrence of donor-derived infections. The liver recipients with donor-derived multidrug-resistant Enterobacteriaceae infections can have good outcome if appropriate antimicrobial therapy is given.

Citing Articles

Expert consensus on perioperative management of liver transplantation in adults with acute-on-chronic liver failure.

Liver Res. 2025; 5(2):37-44.

PMID: 39959341 PMC: 11791809. DOI: 10.1016/j.livres.2021.03.002.

Multidrug-resistant organism bloodstream infections in solid organ transplant recipients and impact on mortality: a systematic review.

Liu A, Dennis A, Fariha Z, Pai Mangalore R, Macesic N JAC Antimicrob Resist. 2024; 6(5):dlae152.

PMID: 39386374 PMC: 11463335. DOI: 10.1093/jacamr/dlae152.

Development and validation of a model for early survival prediction following liver transplantation based on donor and recipient characteristics.

Xie Z, Lin X, Wang Y, Chen Z, Zeng P, He X Ann Med. 2024; 56(1):2410404.

PMID: 39351705 PMC: 11571776. DOI: 10.1080/07853890.2024.2410404.

The utilization of nanopore targeted sequencing proves to be advantageous in the identification of infections present in deceased donors.

Yao Z, Liu Y, Zhan L, Qiu T, Li G, Chen Z Front Microbiol. 2023; 14:1238666.

PMID: 37664117 PMC: 10469296. DOI: 10.3389/fmicb.2023.1238666.

Establishment of a risk prediction model for multidrug-resistant bacteria in deceased organ donors: a retrospective cohort study in China.

Shen G, Zhang L, Fan W, Lv H, Wang F, Ye Q Front Cell Infect Microbiol. 2023; 13:1181630.

PMID: 37305411 PMC: 10249958. DOI: 10.3389/fcimb.2023.1181630.

References

Zibari G, Lipka J, Zizzi H, Abreo K, Jacobbi L, McDonald J . The use of contaminated donor organs in transplantation. Clin Transplant. 2000; 14(4 Pt 2):397-400. DOI: 10.1034/j.1399-0012.2000.14040702.x. View

Sifri C, Ison M . Highly resistant bacteria and donor-derived infections: treading in uncharted territory. Transpl Infect Dis. 2012; 14(3):223-8. DOI: 10.1111/j.1399-3062.2012.00752.x. View

Fishman J, Greenwald M, Grossi P . Transmission of infection with human allografts: essential considerations in donor screening. Clin Infect Dis. 2012; 55(5):720-7. DOI: 10.1093/cid/cis519. View

Kirchner V, Pruett T . Receiving the Unwanted Gift: Infection Transmission through Organ Transplantation. Surg Infect (Larchmt). 2016; 17(3):318-22. DOI: 10.1089/sur.2016.009. View

Green M, Covington S, Taranto S, Wolfe C, Bell W, Biggins S . Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee. Transplantation. 2015; 99(2):282-7. DOI: 10.1097/TP.0000000000000584. View

Freeman R, Giatras I, Falagas M, Supran S, OConnor K, Bradley J . Outcome of transplantation of organs procured from bacteremic donors. Transplantation. 1999; 68(8):1107-11. DOI: 10.1097/00007890-199910270-00008. View

Ariza-Heredia E, Patel R, Blumberg E, Walker R, Lewis R, Evans J . Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. Transpl Infect Dis. 2012; 14(3):229-36. DOI: 10.1111/j.1399-3062.2012.00742.x. View

Fishman J, Grossi P . Donor-derived infection--the challenge for transplant safety. Nat Rev Nephrol. 2014; 10(11):663-72. PMC: 7097136. DOI: 10.1038/nrneph.2014.159. View

Martins N, Martins I, de Freitas W, de Matos J, Magalhaes A, Girao V . Severe infection in a lung transplant recipient caused by donor-transmitted carbapenem-resistant Acinetobacter baumannii. Transpl Infect Dis. 2011; 14(3):316-20. PMC: 3307813. DOI: 10.1111/j.1399-3062.2011.00701.x. View

10.

Mularoni A, Bertani A, Vizzini G, Gona F, Campanella M, Spada M . Outcome of Transplantation Using Organs From Donors Infected or Colonized With Carbapenem-Resistant Gram-Negative Bacteria. Am J Transplant. 2015; 15(10):2674-82. DOI: 10.1111/ajt.13317. View

11.

Gao F, Ye Q, Wan Q, Liu S, Zhou J . Distribution and resistance of pathogens in liver transplant recipients with Acinetobacter baumannii infection. Ther Clin Risk Manag. 2015; 11:501-5. PMC: 4381901. DOI: 10.2147/TCRM.S82251. View

12.

Watkins A, Vedula G, Horan J, Dellicarpini K, Pak S, Daly T . The deceased organ donor with an "open abdomen": proceed with caution. Transpl Infect Dis. 2012; 14(3):311-5. DOI: 10.1111/j.1399-3062.2011.00712.x. View

13.

van der Vliet J, Tidow G, Kootstra G, van Saene H, Krom R, Sloof M . Transplantation of contaminated organs. Br J Surg. 1980; 67(8):596-8. DOI: 10.1002/bjs.1800670822. View

14.

Camargo J . Donor-derived infections in solid organ transplant recipients: Challenging the 30-day paradigm. Transpl Infect Dis. 2017; 19(2). DOI: 10.1111/tid.12665. View

15.

Miceli M, Gonulalan M, Perri M, Samuel L, Al Fares M, Brown K . Transmission of infection to liver transplant recipients from donors with infective endocarditis: lessons learned. Transpl Infect Dis. 2015; 17(1):140-6. DOI: 10.1111/tid.12330. View

16.

Mills J, Wilck M, Weikert B, Porrett P, Timko D, Alby K . Successful treatment of a disseminated infection with extensively drug-resistant Klebsiella pneumoniae in a liver transplant recipient with a fosfomycin-based multidrug regimen. Transpl Infect Dis. 2016; 18(5):777-781. PMC: 5050106. DOI: 10.1111/tid.12578. View

17.

Wolfe R, Roys E, Merion R . Trends in organ donation and transplantation in the United States, 1999-2008. Am J Transplant. 2010; 10(4 Pt 2):961-72. DOI: 10.1111/j.1600-6143.2010.03021.x. View

18.

Garzoni C, Ison M . Uniform definitions for donor-derived infectious disease transmissions in solid organ transplantation. Transplantation. 2011; 92(12):1297-300. DOI: 10.1097/TP.0b013e318236cd02. View

19.

Ruiz P, Gastaca M, Gonzalez J, Hernandez M, Ventoso A, Valdivieso A . Incidence and clinical relevance of bacterial contamination in preservation solution for liver transplantation. Transplant Proc. 2009; 41(6):2169-71. DOI: 10.1016/j.transproceed.2009.06.036. View

20.

Lumbreras C, Sanz F, Gonzalez A, Perez G, Ramos M, Aguado J . Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients. Clin Infect Dis. 2001; 33(5):722-6. DOI: 10.1086/322599. View